BONTAC успешно провёл 60-й вице-президент Салона индустрии здравоохранения Шэньчжэня
Введение
26 июля 2024 года BONTAC совместно с Ассоциацией развития индустрии здравоохранения Шэньчжэня успешно провели 60-й Салон вице-президента индустрии здравоохранения Шэньчжэня с темой «Зелёные биотехнологии, создание здоровой и лучшей жизни».This event was professionally guided by the Joint Party Committee of Related Associations in Shenzhen Health Industry and Shenzhen Health Care Association, as well as strongly supported by Shenzhen Social Organization Exchange Service Exhibition Site.
Под руководством госпожи Хуан, исполнительного директора Ассоциации развития индустрии здравоохранения Шэньчжэня, более 40 членов собрались для изучения новых тенденций и инновационных возможностей в сфере здравоохранения.
Advancing Biotechnology and Shaping the Health Industry's Future
As the event commenced, participants were first guided through BONTAC's exhibition hall, where they were granted an enriched and comprehensive insight into the company's developmental journey, robust R&D strength, and innovative product lineup.
Subsequently, at the symposium, Dr. Cheung, BONTAC Chief Scientist, gave a keynote speech titled "Efficient and Green Biosynthesis of Natural Products Such as Гинсенозид and NMN”, delving into the profound applications and promising future of synthetic biology in the sustainable production of natural compounds like ginsenoside and NMN. Afterwards, Mr. Zhang, BONTAC’s Director of Development Strategy, outlined the company's current trajectory and future aspirations, articulating a grand vision for collaborative innovation with diverse partners to advance the frontiers of biotechnology.
Господин Ву, выдающийся юрист из офиса юридической фирмы Beijing Jingsh Law Firm в Шэньчжэне, предоставил ценные сведения компаниям-членам через глубокий анализ ключевых факторов международного расширения китайских фармацевтических предприятий и медицинских товаров, сосредоточившись на интеллектуальной собственности и соблюдении нормативных требований.
Во время интерактивных сессий участники вели глубокие дискуссии по ключевым темам, включая применение синтетической биотехнологии и глобальные стратегии расширения предприятий. Доктор Чеунг дал подробные ответы на соответствующие запросы.
Meanwhile, the Association's inaugural council for 2024 took place at BONTAC. Ms. Huang reviewed the accomplishments of the first half of the year and outlined the strategic priorities for the latter half, which encompass organizing the Shenzhen Health Conference, releasing the industry's development report, and advancing the establishment of group standards. These initiatives are poised to amplify the Association's impact and foster the health industry's sustainable growth.
After a group photo session, the guests engaged in a profound dialogue with the BONTAC team at the conclusion of the event. This interaction not only provided them with a deeper insight into BONTAC's high-quality products, but also enhanced their appreciation of the company's innovative ethos and product strengths. Concurrently, the event infused new energy and momentum into the health industry's ongoing innovation and advancement.
Видение будущего
Moving forward, BONTAC remains committed to the philosophy of 'Green Bio-Tech, creating a healthy and better life”, pushing the development of synthetic biology and making significant contributions in the realm of human health. We are looking forward to collaborating with a broader array of partners to open a new and vibrant chapter in the health industry.
О BONTAC
As a pioneering force in the NMN industry, BONTAC stands as a national high-tech enterprise integrating R&D, production, and sales around synthetic biotechnology with bio-enzyme catalysis at its core. Notably, BONTAC boasts the world's first whole-enzyme technology and has achieved two 'firsts': pioneering mass production of NMN and NMNH, and being the first in China to synthesize rare natural products like ginsenosides, steviosides, and salidroside. Furthermore, BONTAC has established the inaugural and sole provincial coenzyme engineering technology research center in Guangdong China, significantly contributing to the advancement of synthetic biology.
.jpg?imageView2/1/w/360/h/200)
